Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
NCT04256759
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Pruritus
Interventions
DRUG:
Dupilumab 300Mg Solution for Injection
Sponsor
Mayo Clinic
Collaborators
[object Object]